Skip Navigation



Journal of the National Cancer Institute Advance Access published online on November 5, 2009
JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djp390
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Howell, S. J.
Right arrow Articles by Armstrong, A. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howell, S. J.
Right arrow Articles by Armstrong, A. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved.

CORRESPONDENCE

Re: Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

Sacha J. Howell, Andrew M. Wardley, Anne C. Armstrong

Affiliation of authors: Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, UK (SJH, AMW, ACA)

Correspondence to: Sacha J. Howell, MD, PhD, Department of Medical Oncology, The Christie NHS Foundation Trust, Wilmslow Rd, Manchester M204BX, UK (e-mail: showell@picr.man.ac.uk).

The first 10% of the full text of this article appears below.

Data in the article of Cheang et al. (1) help to define relatively high- and low-risk estrogen receptor–positive breast cancers by using human epidermal growth factor receptor 2 . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?